Abstract
The aim of this study is to fully explore and elucidate the ways in which nanosensor technology has transformed drug analysis, emphasizing both its benefits over traditional techniques and its potential to help fulfill the (SDGs) Sustainable Development Goals. The purpose of this study is to fill in the gap in the current literature on the analysis of drugs, which mostly concentrates on traditional techniques. By addressing the drawbacks of conventional approaches, such as their high procedural complexity and low sensitivity, nanosensors provide an innovative approach for drug analysis. This paper examines the benefits of drug analysis using Nanobiosensors, such as their increased sensitivity, quick detection, and possibility for downsizing. Nanosensor-assisted drug analysis can help achieve SDG 12 by lowering the requirement for resource-intensive conventional procedures and SDG 3 by enabling quick, accurate disease diagnosis and treatment. With continuing development, nanosensor technology has the potential to completely change the pharmaceutical analysis field, spurring innovation and enhancing patient outcomes all around the world. Overall, this study emphasizes the importance of drug analysis using Nanosensors/Nanobiosensor and how they can revolutionize the area, resulting in better healthcare results and sustainable development.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Azerbaijan Pharmaceutical and Pharmacotherapy Journal
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
